| 57.39 Delayed Data As of 10:49am ET |  -1.01 / -1.73%Today’s Change | 50.60 Today|||52-Week Range 97.38 | +0.69% Year-to-Date |
| Previous close | 58.40 |
| Today’s open | 57.60 |
| Day’s range | 57.10 - 57.60 |
| Volume | 14,202 |
| Average volume (3 months) | 198,043 |
| Market cap | $3.1B |
| Earnings growth (last year) | +41.38% |
| Earnings growth (this year) | -6.89% |
| Earnings growth (next 5 years) | +12.50% |
| Revenue growth (last year) | +11.24% |
| P/E ratio | 48.6 |
| Price/Sales | 9.82 |
| Price/Book | 5.44 |
| Today’s change | Today’s % change | |
|---|---|---|
| IMMUImmunomedics Inc | -0.42 | -2.84% |
| QDELQuidel Corp | -0.50 | -0.88% |
| --Quidel Corp | -0.02 | -0.03% |
| MYGNMyriad Genetics Inc | -0.11 | -0.44% |
| Next reporting date | July 22, 2019 |
| EPS forecast (this quarter) | $0.28 |
| Annual revenue (last year) | $402.3M |
| Annual profit (last year) | $63.1M |
| Net profit margin | 15.70% |
Sector Health Technology |
Industry Medical Specialties |
President & Chief Executive Officer John E. Adent |
Chief Financial Officer, Secretary & VP Steven James Quinlan |
Corporate headquarters Lansing, Michigan |
